“Improved Survival Outcomes in Metastatic Colorectal Cancer with Combination Therapy”

https://pubmed.ncbi.nlm.nih.gov/38112050

Combining radiotherapy with anti-angiogenic therapy and immune checkpoint inhibitors can improve survival outcomes in microsatellite stable/mismatch repair proficient metastatic colorectal cancer patients, with manageable toxicity.